The fashion retailer provided a nice buying opportunity when its stock plunged in 2017, but that doesn't guarantee a rebound after its latest slide.
It makes digging a bit harder, but that's been the case for quite a while.
When high expectations are not met, that's when overpaying (for a player or a stock) really stings.
A rising market obviously doesn't hurt these issues that were hammered in 2018, but most also are outperforming a couple key market indices.
Buying Dividend Aristocrats can be a great, long-term play for income investors.
Management needs to reinvent the assets remaining rather than trying to Frankenstein a dead body.
This trio of small-caps is on the rise after a tough few months.
Just because the stock is still down substantially from its all-time highs doesn't mean that it is still 'cheap'.
Is CVS open to those seeking value?
Progress here was overshadowed by the less than stellar forward guidance.